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IntroDuctIon
Gene delivery is an indispensable technique for both basic biological 
research and applied biotechnology; genetically modified cells pro-
vide critical information regarding the involvement of genes and 
gene products in cell development, differentiation and malignancy. 
More recently, transfected cells have become essential materials 
for a wide range of emerging cell therapies and gene therapies that 
have the potential to treat both inherited and acquired disorders1–5. 
A substantial number of these therapies apply an ex vivo approach: 
cells are first isolated from a patient or a donor, then genetically 
modified and selected, before they are introduced into the patient. 
The implanted transfected cells either restore damaged tissues or 
stimulate desired cellular functions such as immune responses. 
These new clinical practices demand advanced methods for genetic 
engineering of cells at various scales.
A variety of transfection methods have been developed for 
genetic modification of cells over the years. Viruses (e.g., retro-
viruses and adenoviruses) with genetically disabled virulence are 
high-efficiency gene transfer vectors. However, retroviruses (includ-
ing oncoretroviruses and lentiviruses) may integrate into the host 
genome and produce insertional mutagenesis6,7. Adenoviruses, 
although nonintegrating, often elicit strong immune responses in 
patients because of the high titers required8–10. Random integration 
and tumorigenesis also limits the use of adeno-associated viruses, 
which generally have low virulence and immunogenicity11–14. 
Alternatively, nonviral methods based on the complexing of DNA 
with cationic lipids or polymers have also been widely applied for 
gene delivery15–17. However, results of these methods are strongly 
dependent on the cell type, the state of the cells and the size of 
the construct. Certain delivery reagents may also induce altered 
gene expression18.
Electroporation is the most widely used physical method for gene 
transfer, with a mechanism that is fundamentally different from 
those of viral or chemical transfection19–23. Electroporation creates 
nanoscale pores in the plasma membrane that allow DNA delivery 
into cells24,25. Electroporation occurs when an external electric field 
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where g(λ) is a function of the membrane and buffer conductivities, 
a is the diameter of the cell, E is the field intensity and θ is the angle 
between the normal to the membrane surface and the field direc-
tion. Classical electroporation is conducted using a high-voltage 
pulse generator that exerts short electric pulses of defined dura-
tion and intensity to a cuvette with embedded electrodes inside. By 
tuning the electric parameters (e.g., field intensity, field duration 
and pulse pattern), gene transfer efficiency and cell viability can be 
optimized. Because of its physical nature, electroporation is simple 
to operate, amenable to miniaturization (which often markedly 
decreases the required voltage)26–31 and yields reproducible results32. 
In comparison with viral and chemical transfection, electropora-
tion offers greatly reduced safety concerns. The major limitations 
associated with electroporation are relatively high cell death rate, 
high cost of the equipment and limited delivery area through the 
cell surface. The last limitation is determined by both the physics 
and the practice of electroporation. On the basis of Equation (1), 
the transmembrane potential ∆ψ
E
 is highest at the poles of a cell 
(i.e., θ → 0) where the surface normal is aligned with the field 
direction. When a cell remains static during the application of the 
electric field (this is typically the case for conventional electropora-
tion given the pulse duration of milliseconds or shorter), permea-
bilization of the membrane and gene delivery occur mostly at the 
poles. The rest of the cell membrane is usually not permeabilized 
under the optimized electroporation conditions (which prevent 
excessive cell death)33,34. The fact that gene entry into cells is via a 
small fraction of the cell surface area creates a profound hurdle for 
improving transfection efficiency.
Flow-through electroporation based on constant voltage
Here we present a protocol for DNA delivery via flow-through elec-
troporation by constant voltage, which is based on previously pub-
lished methods used in our laboratory35,36. In our protocol, instead 
of using a pulse generator, we use a common power supply that 
applies a constant voltage across a fluidic channel. Cell suspension 
mixed with DNA molecules flows through the channel, which has 
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electroporation is a high-efficiency and low-toxicity physical gene transfer method. classical electroporation protocols are 
limited by the small volume of cell samples processed (less than 107 cells per reaction) and low Dna uptake due to partial 
permeabilization of the cell membrane. Here we describe a flow-through electroporation protocol for continuous transfection  
of cells, using disposable devices, a syringe pump and a low-cost power supply that provides a constant voltage. We show 
transfection of cell samples with rates ranging from 40 ml min − 1 to 20 ml min − 1 with high efficiency. By inducing complex 
migrations of cells during the flow, we also show permeabilization of the entire cell membrane and markedly increased Dna  
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multiple sections of designed cross-sectional areas. The local field 
intensity and the cross-sectional area of a particular section are 
inversely proportional. Owing to convenience for fabrication, the 
channel is typically made of uniform depth and composed of wide 
and narrow sections in order to create variation in the cross-sectional 
area. Appropriate combination of the voltage and the channel design 
yields high field intensity in the narrow sections and low intensity 
in the wide sections. The field intensity in the narrow sections is 
beyond the electroporation threshold, whereas the intensity in the 
wide sections does not affect membrane integrity. Cells experience 
electroporation while flowing through the narrow section(s) and the 
duration of electroporation is determined by the residence time(s) 
in the narrow section(s). Having multiple narrow sections in the 
channel renders flowing cells subject to field variations equivalent 
to multiple pulses. The channels can be fabricated at low cost using 
soft lithography. Because the physics of the device does not depend 
on its absolute size, the channel can be easily scaled up and down in 
the range of micrometers to millimeters to accommodate a process-
ing rate from µl min − 1 to ml min − 1. Figure 1 shows the major steps 
involved in the protocol, including (i) photomask design and print-
ing; (ii) master mold fabrication; (iii) polydimethylsiloxane (PDMS) 
device fabrication; (iv) cell and sample preparation; (v) flow-through 
electroporation; and (vi) transfection and viability assays. As a proof 
of principle, pEGFP-C1 plasmid DNA was efficiently transferred into 
Chinese hamster ovary (CHO-K1) cells using this protocol35,36; we 
have not tested the method with other plasmids or cell types.
Advantages and limitations
Our protocol has several unique advantages. First, the flow-through 
format allows us to process sample volumes ranging from microlit-
ers to liters35. This feature facilitates genetic modification of both 
scarce and large-volume samples. The ability to work with tiny 
sample amounts permits functional tests of genes and gene prod-
ucts using cells from limited sources (e.g., animal or human clini-
cal materials). However, for cell therapies, ex vivo transfection on 
the order of 109 cells per patient per trial is routinely required37,38. 
We showed a processing rate of up to 20 ml min − 1 (or 107–108 
cells min − 1) with our flow-through electroporation protocol in 
recent work35. Such an operation is impossible or very difficult 
with conventional cuvette-based electroporators that typically 
handle sample sizes of a few milliliters. Second, our flow-through 
electroporation protocol permits gene delivery through the entire 
cell surface36. As mentioned above, conventional electroporation 
with pulses applied to static cell suspension only permeabilizes 
a small fraction of the cell membrane area. We showed recently 
that, by creating device geometry and flow conditions, which gave 
rise to complex cell migrations, the entire surface area of cells was 
exposed to the electric field for permeabilization during the course 
of the flow36. Such practice markedly improved the uptake with-
out a substantial effect on the cell viability. A high concentration 
of DNA at the cell surface has been identified as a prerequisite 
for high-efficiency transfection39. Finally, our protocol does not 
require expensive equipment. Our protocol is the only electropora-
tion technique that is based on application of constant voltage. This 
unique feature eliminates the need for a pulse generator, which is 
used in virtually all other electroporators. With a low-cost direct 
current (DC) power supply and fluidic channels fabricated by soft 
lithography, we are able to implement sophisticated pulse sequences 
by variations in the design of the channel. The use of constant volt-
age also ensures stable operation and uniform cell treatment over 
an extensive period of processing.
Our flow-through electroporation protocol compares well with 
available commercial devices and techniques, as shown in Table 1. 
Cuvette, well-plate or capillary-based electroporators (e.g., Bio-Rad 
Gene Pulser, Amaxa Nucleofector40–42, Invitrogen Neon system43) 
work in batch mode and produce transfected samples of ~107 cells 
or less per reaction. Our protocol works in a continuous manner 
with a constant output rate up to ~108 cells min − 1 and makes it prac-
tical to transfect liters of cell samples. The physics involved does not 
limit our protocol from further scale-up. MaxCyte offers flow elec-
troporation for large-volume processing44. However, the MaxCyte 
system uses a high-performance pulse generator to continuously 
electroporate flowing cells, and it requires much more sophisticated 
and expensive apparatus than that of our technique. Among all the 
systems, the Amaxa Nucleofection system offers the highest trans-
fection efficiency due to the pulse sequence and buffer ingredients 
(both undisclosed) optimized for each cell type. To our knowledge, 
our protocol is the only electroporation technique that produces 
permeabilization and delivery over the entire cell surface.
One limitation of our protocol is that generating very short 
pulses (~10 µs or shorter) is challenging because this requires very 
fast velocity (up to ~1 m s − 1) in the channel. Fortunately, we found 
that the optimal transfection normally required field durations of 
a few microseconds. Our protocol also shares some of the com-
mon limitations of all electroporation protocols. For example, a 
balance needs to be struck between high transfection efficiency 
and high cell viability. Typically, even under optimized conditions, 
there still is a cell-death rate of 10–20%. Furthermore, for each 
particular cell type, optimization of the electric parameters and 
other operational conditions is necessary. The potential combina-
tions of field intensities, durations and pulse patterns are practically 
endless. Thus, it is important to establish some general guidelines 
about these parameters.
Experimental design
Electric parameters. The most relevant electric parameters for 
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Figure 1 | Flowchart of the flow-through electroporation protocol.  
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In our typical designs, only the electric field in the sections with 
small cross-sectional area of the channel has higher intensity than 
the electroporation threshold (e.g., ~300–400 V cm − 1 for Chinese 
hamster ovary cells)35,36. The field intensity in these sections (i.e., 
the electroporation field intensity) is determined by the constant 
voltage applied across the channel (V) and the geometry of the 
channel. The residence time of cells in these sections (determined 
by the cell velocity and the lengths of these sections) determines 
the electroporation duration. By having multiple electroporation 
sections in series, we are able to deliver a number of pulses to cells 
with designed pattern and sequence, determined by the arrange-
ment of various sections.
Although a constant DC voltage is established across a channel 
that is filled with a conductive buffer, and has multiple sections 
with various cross-sectional areas, based on Ohm’s law, the field 
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and desired electroporation intensity (E
2
) and duration (T
2
), we 
can use the following formulas to calculate the applied voltage (V) 
and the flow rate of a cell sample (Q)
V E L W W L= +2 1 2 1 2( / )
Q W L H T= 2 2 2/
where H is the channel depth.
Multiple pulses created by having multiple narrow sections 
typically produce superior results compared with those created by 
devices with one single narrow section35,46. The arrangement of the 
electroporation sections has a major influence on the transfection 
efficiency. The narrow electroporation sections are segmented by 
the wide sections. Although the low field in the wide sections does 
not generate electroporation, it exerts electrophoretic drag that 
is important for delivering DNA deeply into the cell interior and 
facilitates DNA entry into the nucleus. For example, we showed 
that, whereas the optimal combined T
2
 was in the range of 1–10 ms, 
the combined T
1
 in the wide sections needed to be on the order of 
a few seconds to produce high-efficiency transfection35.
Control of permeabilized membrane area using hydrodynamics. 
The flow-through format of our electroporation protocol allows 
hydrodynamic manipulation of cell motions that strongly influence 
the cell membrane area being permeabilized. In our recent work, we 
showed that by inducing transverse Dean flow in the channel, flow-
through electroporation generated permeabilization over the entire 
cell surface without introducing a substantial decrease in the cell 
viability36. Under these flow conditions, cells are involved in both 
the flow along the channel path and the vortices in the secondary 
transverse direction (i.e., in the plane that is perpendicular to the 
main flow direction). Such complex migrations expose different 
surface areas of a cell to the electric field and overcome the major 
difficulty with conventional electroporation (i.e., limited permea-
bilized membrane area).
The flow conditions and the channel geometry need to meet 
certain criteria in order to generate secondary flows and entrain 
cells in these flows. We found that the channel Reynolds number 
R
c
 and the dimensionless inertial force ratio R
f
 (expressing the rela-
tive magnitudes of inertial lift forces F
L
 and drag forces due to the 
secondary flow F
D
) were crucial measures for determining whether 
cells experienced transverse migration, and whether the permea-
bilization took place at the entire cell surface. The two parameters 
can be calculated by





 is the maximum velocity in the cross-section, D
h
 is the 
hydraulic diameter of the channel, which is defined as 2wh / (w  +  h) 
(with w and h being the width and depth of the channel), and v is 
kinematic viscosity, and
R Ra Df h= 2 2 3/
where R is the radius of curvature of the channel and a is the cell 
diameter. In general, a combination of low R
f
 and high R
c
 provides 
the most favorable conditions for vortex-assisted electroporation 
by inducing a high degree of entrainment in the secondary flow. For 
example, we showed that in the region of R
f
  <  1 and R
c
  >  30, cells 
were effectively entrained in the secondary Dean flow and experi-
enced enhanced DNA delivery36. We showed that, by introducing 
secondary flows in a spiral channel, flow-through electroporation 
permeabilized the entire cell membrane and both DNA uptake and 
transfection efficiency were markedly improved36. In addition, we 
achieved similar cell viability with spiral channels as with straight 
channels (which generated no transverse vortices and led to much 
smaller permeabilization area)36. We speculate that the cell viability 
is much more affected by Joule heating (which is determined only 
by the field intensity and duration) than by the permeabilized cell 
membrane area.
Scaling up. The physics associated with the flow-through electro-
poration and the secondary flows is not dependent on the actual 
size of the channel. Flow-through electroporation is thus fully scal-
able. We have tested channels with feature sizes ranging from tens 
of micrometers to millimeters, with the processing rates between 
40 µl min − 1 and 20 ml min − 1 (ref. 35). We typically scale up the devices 
by increasing the cross-sectional area by the same factor for all the 
sections in the channel. We need to vary the flow rate of the cell 
sample accordingly in order to maintain the same field durations. 
We noticed that the transfection efficiency and cell viability showed 
some dependence on the device size35. Such dependence could be 
substantial when there was only one narrow section in the channel. 
When channels with one narrow section were used, longer T
2
 was 
required in a larger device in order to yield transfection efficiency 
comparable to that yielded by a smaller device35. This is presum-
ably due to weakened electroporation in a larger device, although 
the exact physics behind this is not clear. However, as a result of 
the improved electroporation efficiency associated with applying 
multiple pulses35, channels with multiple narrow sections did not 
show a substantial loss in the transfection efficiency when scaled up. 
In general, after optimization of the operational parameters, similar 




SU-8 2025 and SU-8 2150 photoresist (MicroChem) ! cautIon Photo-
resist is toxic and flammable. Handle only in a chemical fume hood with 
appropriate personal protective equipment.  crItIcal The SU-8 2000 
series of photoresists are highly sensitive to light. Store at 4 °C and process 
in a room protected from light.  crItIcal There are, in total, 12 kinds of 
SU-8 2000 series photoresists. Each photoresist has different viscosities and 
densities. Choose an appropriate photoresist for fabricating devices with 
•
desired channel depths. See MicroChem data sheets for process guidelines 
(http://www.microchem.com/Prod-SU82000.htm). SU-8 2025 and 2150 are 
used in this protocol.
SU-8 developer (1-methoxy-2-propyl acetate; MicroChem) ! cautIon It is 
toxic and flammable. Handle only in a chemical fume hood with  
appropriate personal protective equipment.
Isopropanol (Fisher Scientific, cat. no. A516-4) ! cautIon It causes  
irritation and is flammable. Handle only in a chemical fume hood with  
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Acetone (Fisher Scientific, cat. no. A494-4) ! cautIon It causes irritation 
and is flammable. Handle only in a chemical fume hood with appropriate 
personal protective equipment.




; Electron Microscopy  
Sciences, cat. no. 26212-02) ! cautIon It is a strong oxidizer, corrosive, 
toxic by ingestion and a carcinogen. Handle only in a chemical fume hood 
with appropriate personal protective equipment.
Ammonium hydroxide solution (27% (vol/vol); NH
4
OH; Fisher  
Scientific, cat. no. A669C-212) ! cautIon It is corrosive and toxic by 
ingestion. Handle only in a chemical fume hood with appropriate personal 
protective equipment.
PDMS (Polydimethylsiloxane) prepolymer and curing agent (General  
Electric Silicones RTV 615; MG chemicals) ! cautIon It is an irritant. 
Handle with appropriate personal protective equipment.
Cell culture and sample preparation
CHO-K1 cells (ATCC)
pEGFP-C1 plasmid (Clontech), cat. no 6084–1.
DMEM (Invitrogen, cat. no. 11971) for CHO-K1 cell culture
FBS (Invitrogen, cat. no. 10082)
Penicillin-streptomycin solution (Invitrogen, cat. no. 15140)
l-glutamine solution (Invitrogen, cat. no. 25030) ! cautIon It is an  
irritant. Handle with appropriate personal protective equipment.
Trypsin-EDTA 4Na solution (0.05% (wt/vol); Invitrogen, cat. no. 25300)
PBS tablet (Sigma-Aldrich, cat. no. P4417)
Tris(hydroxymethyl)aminomethane (Sigma-Aldrich, cat. no. 154563)  
! cautIon It is an irritant. Handle with appropriate personal protective 
equipment.
EDTA (Sigma-Aldrich, cat. no. E6758) ! cautIon It is an irritant. Handle 
with appropriate personal protective equipment.
Sodium hydroxide (NaOH; Sigma-Aldrich, cat. no. S5881) ! cautIon It is  
corrosive. Handle with appropriate personal protective equipment.
Hydrochloric acid (HCl; Fisher Scientific, cat. no. A144C-212) ! cautIon  
It is corrosive. Handle with appropriate personal protective equipment.
Electroporation and related assays




; Sigma-Aldrich, cat. no. P5655)




; Sigma-Aldrich, cat. no. S5136)




O; Sigma-Aldrich,  
cat. no. 63138)
Sucrose (Sigma-Aldrich, cat. no. S9378)
YOYO-1 (1 mM solution in DMSO; Invitrogen, cat. no. Y3601)  
! cautIon It is an irritant. Handle with appropriate personal protective 
equipment.
Propidium iodide (PI; Invitrogen, cat. no. P1304MP) ! cautIon It is an irritant 
and a potent mutagen. Handle with appropriate personal protective equipment.
EQUIPMENT
Master fabrication
Computer-aided design software (Macromedia Freehand MX and  
Autodesk AutoCAD)
Silicon wafers (3-inch diameter; University Wafer)
Spin coater (WS-400-6NPP-LITE; Laurell Technologies)
Hot plates
UV illuminator (OminiCure S1000; EXFO Life Science & Industrial  
Division) ! cautIon Use with proper UV protection.
Alignment tools
Plastic containers and tanks
Wash bottles
Tweezers







Microscope glass slides (75 × 25 mm, 1 mm thick; 75 × 50 mm, 1 mm thick; 
and 45 × 50 mm, 170 µm thick)
Glass slide racks


























































Plasma cleaner (Harrick Plasma) and vacuum pump
Solution preparation
Milli-Q Direct system (Millipore)
Glass syringe with Lure-Lock tip (50 ml)
Sterile syringe filters with 0.2 µm pore diameter
Cell culture and sample preparation
Laminar flow hood
Tissue culture incubator set at 37 °C with humidified, 5% CO
2
 atmosphere
Cell culture flasks and well plates
Pipettes/tips







 crItIcal The system should be sterilized with UV irradiation in a laminar 
flow hood overnight prior to the experiment.
Syringe pump (Fusion 400; Chemyx)
Sterile syringes with Luer slip tip (1 ml; Becton Dickinson)
Sterile syringes with Luer-Lock tip (6 ml; Kendall)
Female Luer adaptor (IDEX Health & Science, cat. no. P-678)
Tubing, 1/16 inch (IDEX Health & Science, cat. no. 1622L)
Flangeless ferrule, 1/16 inch (IDEX Health & Science, cat. no. P-200)
Male flangeless nut, 1/16 inch (IDEX Health & Science, cat. no. P-201)
Tubing, 1/8 inch (IDEX Health & Science, cat. no. 1641L)
Flangeless ferrule, 1/8 inch (IDEX Health & Science, cat. no. P-300)
Male flangeless nut, 1/8 inch (IDEX Health & Science, cat. no. P-301)
DC power supply (PS350; Stanford Research System) with alligator  
clip leads
Plastic-coated copper wire
Platinum wire (0.5 mm in diameter, Premion, 99.997%; Alfa Aesar,  
cat. no. 10957)
Microscope
Inverted phase-contrast and epifluorescence microscope system with 100 W 
mercury lamp (IX-71; Olympus) equipped with ×10 and ×20 objectives
High-resolution CCD camera (Hamamatsu, ORCA-285)
Fluorescence filter cubes (For EGFP and YOYO-1: exciter HQ480/40x, 
emitter HQ535/50m and beamsplitter Q505LP; for PI: exciter HQ535/50x, 
emitter HQ645/75m and beamsplitter Q565LP; Chroma Technology)
Confocal fluorescence microscope system (LSM 510; Carl Zeiss) equipped 
with a ×63, 1.4 NA oil-immersion objective
Image acquisition software (QImaging QCapture Pro)
Stage micrometer
ImageJ software (or similar)
REAGENT SETUP
Glass slide cleaning solution Add one volume of 27% (vol/vol) ammonium 
hydroxide and 1 volume of 30% (vol/vol) hydrogen peroxide to five volumes 
of ultrapure water in a glass beaker. Heat the solution on a hot plate stirrer 
and maintain at 75 °C.  crItIcal Prepare the solution immediately before 
cleaning the slides. The cleaning solution becomes useless when stored for  
24 h at room temperature (25 °C).
TE buffer TE buffer comprises 10 mM Tris-HCl and 1 mM EDTA, pH 8.0. 
Prepare 1 M Tris-HCl (pH 8.0) stock solution by dissolving 12.14 g Tris(hydr
oxymethyl)aminomethane in 80 ml of water and adjusting pH to 8.0 with con-
centrated HCl solution; add water to adjust the volume to 100 ml. Prepare 500 
mM EDTA (pH 8.0) stock solution by dissolving 14.612 g of EDTA in 80 ml of 
water and adjusting pH to 8.0 with concentrated NaOH solution; add water to 
adjust the volume to 100 ml. Prepare 10 mM Tris-HCl and 1 mM EDTA, pH 
8.0, from the respective stock solutions. Filter with a 0.2-µm membrane, and 
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EDTA and sodium hydroxide are irritants. Hydrochloric acid is corrosive. 
Prepare the solution with appropriate personal protective equipment.
Plasmid DNA Prepare in advance using any standard protocol or com-
mercially available plasmid preparation kit, e.g., QIAfilter Plasmid Giga 
Kit (Qiagen, cat. no. 12291). Dissolve purified plasmid DNA in TE buffer 
(pH 8.0). Determine the DNA concentration and purity by UV absorbance 
at 260 and 280 nm. Split the plasmid DNA solution into multiple aliquots 
to avoid repeated freeze-thaw cycles and store them at  − 20 or  − 80 °C for 
up to 1 year without marked degradation. pEGFP-C1 plasmid (Clontech) 
encoding enhanced GFP (EGFP) is used as a model to facilitate observation. 
 crItIcal For optimal transfection, plasmid DNA should be of high quality 
and free of proteins (especially nucleases), other contaminating nucleic acids 
and chemicals. Impurities such as salts, ethanol and endotoxin could result 
in reduced transfection efficiency and cell viability. For reliable DNA purity, 
the ratio of absorbance at 260 versus 280 nm (A260/280) should be between 
1.8 and 2.0. A ratio of  <1.8 suggests the contamination of proteins or other 
UV absorbers, and a ratio of  > 2.0 indicates the presence of chemicals. In both 
cases, it is advisable to re-extract the plasmid DNA.
Cell culture medium Use appropriate cell culture medium for specific  
cell types. For CHO-K1 cells, the medium is DMEM supplemented with  
10% (vol/vol) FBS, 2 mM l-glutamine, 100 U ml − 1 penicillin and 100 mg 
ml − 1 streptomycin. Store at 4 °C for up to 1 year.
Sterile PBS Dissolve one PBS tablet in 200 ml of ultrapure water. Autoclave 
for 20 min to sterilize. Store at 4 °C for up to 1 year.


























O and 85.575 g of sucrose in 1 liter  
of water, and adjust pH to 7.4. Filter with a 0.2-µm membrane and store at  
4 °C for up to 6 months.  crItIcal The concentrations of salts in the buffer 
are maintained low in order to generate a solution conductivity of ~0.14 S m − 1, 
whereas sucrose is added to keep the buffer isotonic. More conductive buffers 
may lead to gas bubble formation (hydrolysis) upon application of the  
voltage and cause excessive Joule heating that lowers cell viability.
PI stock solution Dissolve 1 mg of PI in 1 ml of PBS at 1 mg ml − 1. Store at  
4 °C, protected from light, for up to 1 year.
PI working solution Dilute PI stock solution to 1 µg ml − 1 with PBS (1:1,000 
of dilution from stock). Store at 4 °C, protected from light, for up to 1 month.
EQUIPMENT SETUP
Wafer treatment Silicon wafers should be precleaned and dehydrated 
before fabrication to enhance the adhesion of photoresist onto the wafers. 
Immerse the silicon wafer in acetone for 5 min, and rinse with isopropanol. 
Immerse the silicon wafer in isopropanol for 5 min, and rinse with deion-
ized water. Blow-dry with clean air. Bake on a hot plate at 200 °C for 5 min 
to remove the adsorbed water from wafer surface. Cool down to room tem-
perature for photoresist coating, or store in a clean and dry environment. 
! cautIon Acetone and isopropanol cause irritation and are flammable. 
Handle only in a chemical fume hood with appropriate personal protective 
equipment.
Glass slide cleaning Place the glass slides in a glass beaker with slide 
racks, add the cleaning solution (see REAGENT SETUP for detail) and 
cover the beaker with a sheet of aluminum foil. Heat the slides at 75 °C 
on a hot plate, and stir the solution continuously with a magnetic stir bar. 
After 3 h, remove glass slides with tweezers, rinse with ultrapure water and 
thoroughly blow-dry them with clean air. Place the cleaned glass slides in 
a slide storage box.  crItIcal This process is used to remove organic 
residues such as alkanethiols from the glass surface by oxidization, during 
which oxygen bubbles are generated vigorously in the solution. ! cautIon 
Both ammonium hydroxide and hydrogen peroxide are highly toxic.  
Perform this step in a chemical hood and use appropriate personal 
 protective equipment.
proceDure
Design and printing of photomasks ● tIMInG 1 h for design and 1–4 d for printing
1| Draw patterns with a computer-aided design software, such as Macromedia FreeHand MX or Autodesk AutoCAD.  
Figure 2 shows four examples of the designs: first, multiple alternating wide and narrow sections with different sizes  
(a and b in Fig. 2); second, two wide sections and one straight narrow section (c in Fig. 2); and, finally, two wide sections 
and one spiral narrow section (d in Fig. 2).
 crItIcal step SU-8 2000 is a series of epoxy-based negative photoresists. Channel patterns should be drawn as  
transparent area, allowing UV light to pass through the photomask and cross-link the SU-8 2000 photoresist.
2| For straight channels, print the design on high-resolution (5,080 dpi) film transparencies. For spiral channels,  
print the pattern on glass with a layer of chromium to generate chrome masks with higher resolution. Many commercial  
suppliers provide a printing service, such as University of Illinois at Urbana-Champaign Facilities & Services Printing  
Department (http://130.126.4.33/scripts/contacts.cgi) and Purdue University Birck Nanotechnology Center  
(https://engineering.purdue.edu/NANO/Microfab).
 crItIcal step Film transparency is suitable for patterns with relatively large sizes ( >20 µm), and is much cheaper  
than chrome masks.
Fabrication of masters ● tIMInG 0.5–3.5 h
3| Turn on the nitrogen cylinder, which is connected to the spin coater, and set the pressure to 60 psi.
4| Place a 3-inch silicon wafer on the center of the spinner chuck and apply vacuum to hold the wafer.
 crItIcal step The position of the wafer will need fine adjustments to ensure uniform spread of photoresist on the wafer.
5| Pour ~5 ml of SU-8 2000 photoresist on the center of the wafer. Spin the wafer with an appropriate spin speed to obtain 
the desired film thickness. Determine the required spin speed and time from spin curves (see MicroChem data sheet on SU-8 
2000). As an example, for a thickness of 75 µm with SU-8 2025, set the speed to 100 r.p.m. for 5 s and then 1,000 r.p.m. for 
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 crItIcal step It is important to choose the appropri-
ate photoresist with the required viscosity and density for 
fabricating devices with the desired channel depth (see 
REAGENTS section for additional information).
! cautIon SU-8 2000 series photoresists are toxic and  
flammable. Handle only in a chemical fume hood with  
appropriate personal protective equipment.
? trouBlesHootInG
6| Transfer the coated wafer onto a hot plate with  
tweezers. Soft-bake at 95 °C to evaporate the solvent and 
harden the photoresist (Fig. 3b).
 crItIcal step The soft-baking time depends on the  
photoresist thickness. Optimize the process to ensure that 
no film ‘wrinkling’ occurs.
 crItIcal step The hot plate must be leveled. Otherwise, 
the thickness of the photoresist on the wafer will not  
be uniform.
7| Cool down the wafer to room temperature. Align the 
photomask on top of the wafer and place a blank glass plate 
on the transparency photomask. Expose to UV light (energy 
density between 585 and 600 mJ cm − 2) for 17–20 s to  
replicate the pattern into the photoresist (Fig. 3c).
 crItIcal step The optimal exposure intensity and time depends on the photoresist thickness and the UV source.
! cautIon UV radiation is harmful to eyes. Wear protective goggles or a face shield, and avoid directly looking at the UV 
source during exposure.
8| Immediately after exposure, bake the wafer on a hot plate at 95 °C to cross-link the exposed areas of the  
photoresist (Fig. 3d).
 crItIcal step The post-baking time is determined by the photoresist thickness.
9| Cool down the wafer to room temperature. Submerge the wafer into SU-8 developer and manually agitate until all  
unexposed photoresist is removed. Briefly wash the tweezers with developer to remove the photoresist remaining on the  
tips (Fig. 3e).
 crItIcal step The optimal development time varies with film thickness.
! cautIon SU-8 developer is toxic and flammable. Handle only in a chemical fume hood with appropriate personal  
protective equipment.
? trouBlesHootInG
10| Briefly rinse the wafer with isopropanol several times and then blow-dry it with a gentle stream of air (Fig. 3f).
? trouBlesHootInG
11| When an ultrathick photoresist such as SU-8 2150 is used, hard-bake the wafer at 150 °C on a hot plate to improve the 
adhesion between the photoresist and wafer. Cool down the wafer before proceeding to the next step.
 crItIcal step The optimal hard-baking time depends on the film thickness.
Narrow sectionWide section
W1 (µm) W2 (µm)L1 (µm) L2 (µm)
H (µm)
4,000 + 4 × 30,000 + 4,000 5 × 200




















| Examples of photomasks used for fabricating flow-through 
electroporation devices. The narrow sections are not magnified by the same 
proportion. The channel patterns are designed as transparent areas allowing 
UV penetration. The table shows the dimensions of the channels. W1: the 
width of the wide sections; L1: the total length of wide sections; W2: the 
width of the narrow sections; L2: the total length of the narrow sections;  
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12| Inspect the master (i.e., photoresist patterned on the 
wafer) under a microscope to check whether the edges are 
sharp and the feature dimensions are the same as designed. 
Place the master in a closed 100-mm Petri dish for storage.
 pause poInt The master can be stored in a dry and clean 
environment indefinitely.
? trouBlesHootInG
Fabrication of pDMs devices ● tIMInG 4.5 h plus 
overnight sterilization
13| Weigh PDMS prepolymer and curing agent at the ratio  
of 10:1 (RTV615A base: RTV615B curing agent) in a  
disposable polystyrene weighing dish. To ensure that the 
curing agent is evenly distributed, stir the mixture  
vigorously with a clean glass stirring rod until the mixture 
becomes milky. Avoid introducing dust particles into the 
PDMS mixture.
 crItIcal step The ratio between the PDMS prepolymer 
components and thorough mixing are critical. If the curing 
agent is not sufficient and/or not mixed thoroughly, PDMS 
may not be completely cross-linked; such PDMS devices are 
easily torn upon insertion of tubing and electrodes.
! cautIon Wear powder-free gloves when handling the PDMS prepolymer.
14| Place the weighing dish containing the PDMS mixture into a vacuum desiccator and evacuate the chamber.  
Degas under vacuum for 2 h until all bubbles disappear. Turn off the vacuum and slowly vent the desiccator.
15| Slowly pour the PDMS mixture over the master in a Petri dish. Take care not to introduce bubbles into the Petri dish.  
If there are still some bubbles remaining, remove them with a disposable transfer pipette or place the master/PDMS back 
under the vacuum for a while. For a 100-mm Petri dish, ~30 g of the mixture is required to generate a ~5 mm layer (Fig. 4a).
16| Cure PDMS in an oven at 80 °C for 1–2 h to generate a PDMS layer that is transparent and solid (Fig. 4b).
17| After cooling PDMS to room temperature, gently cut the patterned area of the cured PDMS replica with a razor blade and 
peel it from the master. Place it, with the feature side facing down, on a smooth bench surface covered by a clean sheet of 
aluminum foil. Cut the PDMS mold into the desired size. Avoid touching the PDMS surface with the feature (Fig. 4c).
! cautIon The master is brittle and can be easily cracked by the razor blade. Do not exert excessive stress on the wafer  
when cutting.
? trouBlesHootInG
18| Cut a thin slice of the PDMS device along the cross-section of the fluidic channel using a sharp razor blade. Place the 
slice onto a glass slide and measure the depth of the channel under a microscope with the help of a stage micrometer.
? trouBlesHootInG
19| Punch an inlet hole (~1 mm in diameter) and an outlet hole (~5 mm to ~10 mm in diameter for small-volume  






















Figure 3 | Schematic illustration of master fabrication with standard 
photolithography technique. (a–f) Spin-coat SU-8 2000 photoresist on a 
silicon wafer (Steps 3–5) (a); soft-bake on a hot plate to evaporate the 
solvent and harden the photoresist (Step 6) (b); UV exposure to replicate 
the pattern on a photomask into the photoresist (Step 7) (c); post-exposure 
bake on a hot plate to fully cross-link the exposed photoresist (Step 8) (d); 
agitate in SU-8 developer to remove the unexposed photoresist (Step 9) (e); 
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 crItIcal step The punched holes should be slightly 
smaller than the outer diameter of the tubing to ensure a 
waterproof seal under fluidic pressure.
 pause poInt The cured PDMS can be stored at room  
temperature for several days in a clean and closed container.
20| Remove dust particles from PDMS surface with paper 
tape. Use tweezers to place the PDMS and glass slide into 
the plasma cleaner chamber with the surfaces to be bonded 
facing up, and turn on the vacuum pump to evacuate the 
chamber for 5 min.
21| Turn on the plasma cleaner and set the RF (radio  
frequency) level to ‘high’ and open the needle valve slightly 
to let air into the chamber until a bright pink-violet glow 
is observed. Once it is stable, treat the PDMS and the slide 
with plasma for 1 min.
 crItIcal step The oxygen plasma transforms Si-CH3 
groups on the PDMS surface into Si-OH groups. The inter-
action between the plasma and the treated surfaces is 
determined by the intensity and frequency of the RF power, 
the pressure and flow rate of air, the treatment time and the 
characteristics of sample surfaces.
22| Set the RF level to ‘off’. Turn off the plasma cleaner 
and vacuum pump. Open the needle valve slowly to vent the 
chamber. Remove the PDMS and glass slide with tweezers and avoid touching the surfaces that are to be bonded.  
Immediately bring the PDMS into contact against the slide to form closed channels. Press gently to remove air bubbles 
trapped at the interface between the PDMS and the glass if necessary (Fig. 4d).
? trouBlesHootInG
23| Bake the whole device at 80 °C in the oven for another 1 h to enhance the bonding strength between PDMS and glass. (Fig. 4e)
 pause poInt The PDMS devices can be stored at room temperature for several months in clean Petri dishes until use.
24| Sterilize the devices prior to experiments by UV irradiation in a laminar flow hood overnight or by flowing 70% (vol/vol) 
ethanol through the channel for at least 5 min and subsequently flowing ultrapure water for at least 5 min.
cell and sample preparation ● tIMInG ~30 min
25| Harvest cells growing in exponential phase according to standard protocols (using trypsin-EDTA solution for adherent 
cells). Count cells with a hemocytometer. For CHO-K1 cells, culture to 80% confluence.
 crItIcal step Cells to be transfected should be healthy and actively proliferating for best results, because the rapid cell 
division improves transport of DNA into the nucleus. Each cell line has a characteristic optimal confluency and should be 
regularly subcultured. CHO-K1 cells are passaged every 2 d at a ratio of 1:10. Approximately 2 × 106 CHO-K1 cells are yielded 
in one 25 cm2 flask.
 crItIcal step The number of cell passages is also essential for obtaining efficient gene transfer. The characteristics of 
cells (even immortalized cell lines) may change after repeated passages, leading to poor transfection.
 crItIcal step Each cell type has its own optimal digestion time. Avoid overdigestion of cells, which reduces both  
transfection efficiency and cell viability.
 crItIcal step If multiple culture flasks are used, mix all cell suspensions in one tube for cell counting to avoid variability.
Figure 4 | Schematic illustration of PDMS device fabrication using the silicon-
wafer master. (a–e) Dispense degassed PDMS prepolymer and curing agent 
over the master that is placed in a Petri dish (Step 15) (a); cure PDMS in an 
oven at 80 °C (Step 16) (b); cut and punch access holes (Steps 17–19) (c);  
oxidize by plasma treatment and bond to a clean glass slide (Steps  
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26| Centrifuge the required number of cells at 300g for 5 min at room temperature.
27| Slowly aspirate and discard the supernatant, retain ~50 µl of the liquid in the centrifuge tube to avoid cell damage. Add  
4 ml of the electroporation buffer, and gently disperse the cell pellet by pipetting up and down until the cells are resuspended. 
Wash the cells by centrifuging at 300g for 5 min at room temperature and then resuspending in the electroporation buffer.
 crItIcal step High shear stress induced by vigorous pipetting may damage cells and negatively affect cell transfection.
28| Repeat the wash step (Step 27) once.
29| Slowly aspirate and discard the supernatant and resuspend cells with an appropriate volume of the electroporation buffer 
to provide the required density of cells for experiments.
30| Combine the cell suspension with an appropriate amount of plasmid DNA solution to achieve the desired concentrations 
for cells and plasmid DNA. Gently mix the solution by pipetting several times.
 crItIcal step Single cell suspension must be obtained at this point. Cell aggregates may reduce transfection efficiency 
and cell viability or even clog the channel.
 crItIcal step The concentration of plasmid DNA affects transfection efficiency and cell viability. The optimal  
concentration depends on the target cell line and the type of DNA. Excessive amount of plasmids containing potent  
promoters such as the human cytomegalovirus (CMV) immediate early promoter are toxic to cells. Thus, we use 40 µg ml − 1  
of pEGFP-C1 plasmids (containing CMV promoter) and 2 × 106 cells ml − 1 of cells in the electroporation buffer.
31| Aliquot the mixture into microcentrifuge tubes with the volume for one experimental run in each tube. Leave them on ice.
 crItIcal step In our hands, incubation of cells (suspended in the electroporation buffer) on ice decreases later cell death 
by electroporation. However, do not incubate cells on ice for longer than 1 h. Cells may become unhealthy after a long  
incubation on ice, resulting in reduced transfection efficiency and viability.
Flow-through electroporation ● tIMInG 1–2 h
32| For flow-through electroporation (See system setup in Fig. 5a,b), two slightly different procedures can be used, depend-
ing on the transfected cell volume. Option A is for processing small volumes (≤500 µl) of cells (Fig. 5c). Option B is applied 
to large volumes (>500 µl) of cells (Fig. 5d). The electroporation should be performed in a laminar flow hood to reduce 
contamination. To observe the distribution of plasmid DNA on the cell surface after delivery, follow the procedure in Box 1  
to stain the DNA with a fluorescent dye before electroporation. This is necessary when DNA delivery over the entire cell 
surface needs to be confirmed.
(a) For small-volume (≤500 ml) cell transfection
 (i)  Connect a length of 1/16-inch tubing to a 1-ml sterile Luer-tipped syringe with the help of the flangeless fittings 
system and a female Luer adaptor. Slide a 1/16-inch male flangeless nut and a 1/16-inch flangeless ferrule over the 
tubing in order. Finger-tighten the assembly into the female Luer adaptor. Insert the syringe into the Luer adaptor. 
 crItIcal step The tubing assembly is reusable and easy to replace. It should be sterilized by UV irradiation in a 
laminar flow hood overnight before the experiment.
Figure 5 | The setup for flow-through 
electroporation. (a) The entire apparatus in 
operation. A mixture of cells and plasmid  
DNA in the electroporation buffer is introduced 
into the PDMS fluidic channel through plastic 
tubing affixed to the inlet, driven by a syringe 
pump. A power supply connected to two  
platinum wire electrodes establishes a constant 
voltage across the channel. The system is  
placed in a laminar flow hood during operation. 
(b) Details of the platinum electrode insertion 
into the channel. A platinum wire is used as  
an electrode and inserted into the inlet (and  
the outlet in the case of large-volume 
transfection) through elastic PDMS wall.  
A copper wire is prelinked with the platinum  
wire for connection with the wire leads of the 
power supply. The plastic tubing is inserted into a punched hole for transfer of the cell sample. (c) Schematic illustration of the setup for small-volume  
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 (ii) Draw the electroporation buffer into the syringe and tubing, and fix the syringe in a syringe pump.
 (iii)  Insert the tubing filled with liquid into the device inlet as illustrated in Figure 5b. Extensively flush the channel with 
the electroporation buffer for at least 5 min to condition the channel and remove impurities. Prime the channel with 
the electroporation buffer. Gently pull out the tubing from the inlet. 
 crItIcal step Use a microscope to check whether there are air bubbles trapped in the channel, especially at the 
corners of the wide sections. The presence of bubbles may alter the electroporation conditions. 
? trouBlesHootInG
 (iv)  Carefully insert one platinum wire into the inlet through the elastic PDMS wall. Connect the platinum wire to the  
negative terminal of the power supply by clipping the wire lead to the supporting copper wire prelinked with the  
platinum wire, as shown in Figure 5b. 
? trouBlesHootInG
 (v)  Aspirate and discard the liquid in the outlet reservoir. Place the other platinum wire connected to the positive  
terminal of the power supply into the outlet reservoir (punched during fabrication, Step 19). Add a certain volume 
(depending on the size of the outlet reservoir) of the electroporation buffer into the outlet reservoir so that the  
platinum wire is in contact with the solution.
 (vi)  Draw a short plug of air into the tubing by pulling the syringe piston carefully. Then draw the cell/DNA mixture into 
the tubing so that it is separated from the electroporation buffer in the tubing by the air plug. Fill the cell/DNA  
suspension to the end of the tubing and insert the end of the tubing into the inlet of the channel. 
 crItIcal step The volume of the air plug should be small enough to ensure accurate flow rate. 
 crItIcal step Before inserting tubing, ensure that the liquid reaches the end of the tubing to avoid introducing 
air bubbles into the channel. Bubbles may migrate with the flow, block the channel, and thus change the distribution 
of the electric field in the channel or even disconnect the current.
 (vii)  Set the pump parameters (syringe diameter, infusion volume and flow rate) and the electric parameter (voltage). 
Turn on the DC power supply and the syringe pump simultaneously. Flow the cell/DNA solution through the device for 
electroporation, and collect cells from the outlet reservoir with a pipette. When the air plug reaches the channel inlet, 
turn off the pump and power supply promptly. 
 crItIcal step The applied voltage and flow rate can be determined using Equations (2) and (3). 
! cautIon Do not touch the leads of the power supply in order to avoid electric shock when the power is on.
(B) For large-volume (>500 ml) cell transfection
 (i)  Connect a length of 1/8-inch tubing to a 6-ml (or larger) sterile Luer-tipped syringe with the help of the flangeless 
fittings system and a female Luer adaptor. Slide a 1/8-inch male flangeless nut and a 1/8-inch flangeless ferrule over 
the tubing in order. Finger-tighten the assembly into the female Luer adaptor. Insert the syringe into the Luer adaptor. 
Insert a length of 1/16-inch tubing into the other end of 1/8-inch tubing to facilitate affixing to the inlet. 
 crItIcal step Use a syringe with the appropriate volume when working with large-volume cell samples.
 (ii) Draw the electroporation buffer into the syringe and tubing, and fix the syringe in a syringe pump.
 Box 1 | oBSERVING PLASMID DNA DISTRIBUTIoN oN CELL SURFACE ● tIMInG 2 h
1. Label plasmid DNA using the fluorescent dye YOYO-1 at a ratio of 1 dye molecule per 5 bp of the DNA according to the protocol 
provided by the manufacturer (Invitrogen).
! cautIon YOYO-1 is an irritant. Handle with appropriate personal protective equipment.
2. Mix the DNA and YOYO-1 solutions by pipetting and incubate the mixture at room temperature for 1 h in the dark.
 crItIcal step The incubation step should be performed in the dark to prevent photobleaching of the fluorescent dye.
3. Add the fluorescently labeled DNA to cell suspension to achieve a final cell concentration of 2 × 106 cells ml − 1 and DNA  
concentration of 500 µg ml − 1. Gently mix the solution by pipetting several times.
4. Perform flow-through electroporation as described in Step 32 of the PROCEDURE.
5. Immediately after electroporation, transfer the processed cells to a centrifuge tube.
6. Centrifuge the cells at 300g for 5 min at room temperature.
7. Slowly aspirate and discard the supernatant. Wash the cells with 4 ml of PBS by centrifuging at 300g for 5 min at room temperature 
and then discarding the supernatant. The wash removes nonspecifically adsorbed DNA from the cell surface.
8. Repeat the wash (Step 7) once.
9. Resuspend the cells with an appropriate volume of PBS to achieve a concentration of 5 × 106 cells ml − 1.
10. Add a drop of cell suspension to a clean glass cover slip (~170 µm in thickness) and allow the cells to settle for 10 min.
11. View the sample with a confocal fluorescence microscope equipped with an ×63, 1.4 NA oil-immersion objective.  
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 (iii)  Insert the tubing filled with the buffer into the device inlet as illustrated in Figure 5b. Affix an additional length of 
1/16-inch tubing to the outlet (which has a small punched hole instead of a reservoir), and place a tube (or other 
containers) at the other end of the outlet tubing to collect the transfected sample. Extensively flush the channel with 
the electroporation buffer for at least 5 min to condition the channel and remove impurities. Prime the channel with 
the electroporation buffer. The presence of bubbles may alter the electroporation conditions. Gently pull out the tub-
ing from the inlet and outlet. 
 crItIcal step For large-volume transfection, the device outlet should have a small punched hole for affixing  
tubing, and cells are collected into a container. 
? trouBlesHootInG
 (iv)  Carefully insert two platinum wires into the inlet and outlet, separately, through the elastic PDMS wall. Connect  
the platinum wire in the inlet to the negative terminal of the power supply and the one in the outlet to the  
positive terminal by clipping the wire leads to the supporting copper wires prelinked with the platinum wires,  
as shown in Figure 5b. 
? trouBlesHootInG
 (v)  Draw the cell/DNA mixture into the tubing and the syringe. Fill the suspension to the end of the tubing and insert it 
into the inlet. Then also insert the other tubing into the outlet.
 (vi)  Set the pump parameters (syringe diameter, infusion volume and flow rate) and the electrical parameter (voltage). 
Turn on the DC power supply and the syringe pump simultaneously. Flow the cell/DNA solution through the device for 
electroporation, and collect cells with a tube. When all liquid is infused, turn off the pump and power supply promptly. 
If the cell/DNA mixture has a substantial volume in the syringe and the processing time is longer than 5 min, place a 
small magnetic stir bar inside the syringe so that the solution can be periodically stirred by moving a magnet back and 
forth outside the syringe. This practice prevents settling of cells in the syringe.
33| Immediately transfer transfected cells to prewarmed culture medium in a culture plate or flask. Record the electric  
current for each run of electroporation for comparisons between experiments. A stable current indicates smooth operation.
? trouBlesHootInG
34| If necessary, reload the syringe and repeat Steps 32 and 33 until the entire cell sample is treated.
 crItIcal step It is advisable to use a new device for each run especially when a different DNA or cell type is used.
transfection and viability assays ● tIMInG 0.5 h per sample
35| For transient expression, examine cells at 24–72 h post-transfection to evaluate expression of the transfected gene and 
cell viability by staining with PI. Centrifuge the sample at 300g for 5 min at room temperature so that the floating cells  
settle at the bottom of wells or culture flasks.
 crItIcal step The optimal assay time depends on the growth rate of the cell line and the specific expression  
characteristics of the transfected gene. The expression of EGFP in CHO-K1 cells reaches its peak at 48 h after electroporation.
36| Gently aspirate and discard the supernatant. Rinse the cells with prewarmed PBS.
37| Aspirate and discard the PBS. Add PI working solution (1 µg ml − 1 of PI in PBS) and incubate at room temperature in the 
dark for 20 min to stain dead cells.
! cautIon PI is a suspected carcinogen. Wear safety equipment when working with this dye and dispose of it properly.
38| Capture both phase-contrast and fluorescent images of cells at 10 different locations in each sample using an inverted 
phase-contrast/epifluorescence microscope equipped with an ×20 dry objective and a CCD camera. (For EGFP: excitation 
maximum  =  488 nm; emission maximum  =  507 nm. For PI: excitation maximum  =  493 nm; emission maximum  =  632 nm.)
39| Use image analysis software such as ImageJ to enumerate a population of at least 1,500–2,000 cells in each sample.
 crItIcal step When working with a large number of cells, flow cytometry can also be used to analyze the transfection 
efficiency and the cell viability.
40| Calculate the transfection efficiency (the percentage of cells expressing EGFP among viable cells) and cell viability  
(the percentage of viable cells among the total cells processed).
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? trouBlesHootInG
Troubleshooting advice can be found in table 2.
taBle 2 | Troubleshooting table.
step problem possible reason solution
5 Air bubbles trapped in  
photoresist film after spin  
coating
Bubbles are trapped in the  
container that stores photoresist
Heat the container at 50–60 °C to reduce the  
viscosity
Bubbles are generated during  
dispensing
Use a dispenser with a large orifice, i.e., a  
50-ml centrifuge tube
Remove air bubbles with a clean and thin tip
9, 17 Patterns on the wafer lift off Photoresist is underexposed  
by UV
Increase the exposure dose
Photoresist is not sufficiently 
cross-linked
Increase the post-exposure bake time
Photoresist is overdeveloped Reduce the development time
Reduce the agitation during development
10 White traces form on the wafer Photoresist is underdeveloped Immerse the wafer back into SU-8 developer for a  
little bit longer until no white traces are left
Vigorously agitate the wafer during development if 
the photoresist film is thick
12 Pattern distortion and cracks  
for thick photoresist film  
(e.g., SU-8 2150)
Great internal stress is produced 
during fabrication
Optimize UV exposure and post-exposure bake to  
create uniform cross-linking for the photoresist film
Allow the wafer to slowly cool after each baking step
18 PDMS channels fabricated using 
the same master are inconsist-
ent in depth
Photoresist is not uniformly  
coated
Carefully center the silicon wafer on the spinner 
chuck
Dispense the photoresist on the center of the wafer
Relax the photoresist on a leveled surface after spin 
coating, especially for SU-8 2150
Level the hot plate before soft baking
PDMS channel depth is not as 
expected
Spin-coating conditions for  
photoresist are not optimized
Obtain a thickness versus spin speed curve for the 
selected photoresist
Photoresist solvent evaporates, 
making photoresist more viscous
Increase the spin speed
Use a new bottle of photoresist
22 PDMS and glass do not bond Plasma does not form in the 
plasma cleaner chamber
Make sure the plasma cleaner chamber is adequately 
evacuated. Check the vacuum system and plasma 
cleaner door
Plasma treatment time is not  
optimized
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taBle 2 | Troubleshooting table (continued).
step problem possible reason solution
Bonding surfaces are not clean Remove dust particles from the PDMS surface with 




Solution leakage Bonding between PDMS and glass 
is not strong
See TROUBLESHOOTING for Step 22
The inlet (or outlet) of the PDMS 
device is not properly connected 
with the tubing
Punch the inlet (or outlet) with a sharp puncher to 
avoid creating small tears around the access hole or a 
noncircular hole
Make sure that the diameter of the puncher is slightly 
smaller than the tubing’s outer diameter
Carefully insert the tubing and avoid unnecessary 
movement of the tubing
Too much pressure is applied  
to the channel
Decrease the flow rate
32A(iv), 
32B(iv)
Solution leakage along  
platinum wire electrode
The platinum wire is bent or  
too thick
Use a straight platinum wire with a diameter  
of 0.5 mm
33 Inconsistent current reading 
between experiments
Air bubbles block the channel Make sure that no air bubbles are introduced while 
inserting tubing
Prime the channel with the electroporation buffer 
before flowing the cell/DNA mixture
Cells or PDMS scraps clog the nar-
row sections of the channel
Use a new device to perform electroporation
The channel depth varies among 
different PDMS devices
See TROUBLESHOOTING for Step 18
40 Low transfection efficiency The amount of plasmid DNA used 
is low
Increase the plasmid DNA concentration
Plasmid DNA is of poor quality Prepare a new batch of plasmid
Cell quality is poor Ensure that cells are uncontaminated, healthy and 
grown actively in the exponential phase
Do not incubate cell/DNA mixture on ice for  
longer than 1 h
Cell/DNA ratio is inappropriate Transfect the same number of cells using various  
plasmid DNA concentrations to optimize the ratio
Electrical field intensity and  
residence time are inappropriate
Treat cells with different conditions to obtain an  
optimal combination of electric parameters
Channel geometry is not optimized Design a new channel
Post-electroporation culture time  
is not optimized
Observe cells at different times post-electroporation 
to determine the optimal time
Devices are reused for multiple 
times
Use a new device for each run
Low cell viability Excessive plasmid DNA is toxic  
to cells
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● tIMInG
Steps 1 and 2, Design and printing of photomasks: 1 h for design and 1–4 d for printing
Steps 3–12, Fabrication of masters: 0.5–3.5 h, depending on the photoresist thickness
Steps 13–23, Fabrication of PDMS devices: 4.5 h
Step 24, Sterilization of PDMS devices: overnight
Steps 25–31, Cell and sample preparation: ~30 min
Steps 32–34, Flow-through electroporation: typically 1–2 h, depending on the sample amount
Steps 35–40, Transfection and viability assays: 0.5 h per sample
Box 1, Observing plasmid DNA distribution on cell surface: 2 h
antIcIpateD results
This protocol enables continuous transfection of cells by flow-through electroporation in PDMS fluidic channels with  
alternating wide and narrow section(s). Here we show typical results for transfection of CHO-K1 cells by pEGFP-C1 plasmid 
DNA. Figure 6, panel c shows the transfection efficiency and cell viability when DNA delivery is conducted using a chan-
nel with its design in Figure 2a (having a depth of 480 µm and 5 narrow sections). The total voltage V of 763 V is applied 
(leading to 800 V cm − 1 in the narrow sections and 53 V cm − 1 in the wide sections), whereas the flow rate Q changes from 
1.87 to 4.36 ml min − 1 (corresponding to T2 ranging from 7.7 to 3.3 ms). Longer T2 increases the transfection efficiency while  
reducing the cell viability. An optimal transfection efficiency as high as 75% is achieved with T2 of 7.7 ms (with Q of  
1.87 ml min − 1). Figure 6d shows the results obtained with the device having a depth of 412 µm and five narrow sections as 
depicted in Figure 2b. The total voltage V of 784 V is applied (generating 800 V cm − 1 in the narrow sections and 80 V cm − 1 
in the wide sections), whereas the flow rates are varied in the range of 3.94–19.7 ml min − 1 (corresponding to T2 ranging 
from 5.5 to 1.1 ms). The cell viability under these conditions is very high (93–98%) and the highest transfection efficiency 
achieved is 36%.
Figure 7 shows the effects of hydrodynamics on flow-through electroporation. Using the devices shown in Figure 2c  
(a microscale channel with one straight narrow section) and Figure 2d (a channel with the same dimensions as the one 
taBle 2 | Troubleshooting table (continued).
step problem possible reason solution
Plasmid DNA is contaminated with 
bacterial endotoxin and other con-
taminants
Use transfection-grade plasmid DNA. Do not use 
methods involving phenol-chloroform
Cells are damaged Avoid overdigestion of cells by trypsin-EDTA solution
Pipette cells smoothly and gently to avoid air bubbles
Centrifuge cells at lower speed
Do not incubate cell/DNA mixture on ice for more 
than 1 h
Transfer cells into prewarmed culture medium  
immediately after electroporation
Electrical field intensity is  
too high
Reduce the field intensity
Residence time is too long Increase the flow rate
Nonreproducible transfection 
results
Cells’ characteristics change  
over time
Subculture cells regularly and maintain active  
growing. Use a new vial of frozen cells if cells are 
excessively passaged
Channel depth of different PDMS 
devices varies
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in Figure 2c except a spiral narrow section), fluorescently 
labeled DNA molecules are delivered for observing the  
difference in the uptake. The epifluorescence and  
reconstructed 3D confocal images in Figure 7a indicate  
that the delivery is limited to one pole of a cell when the 
flow-through electroporation is conducted in the device  
in Figure 2c with a short T2 of 0.5 ms. In comparison,  
when T2 is increased to 5 ms with the same device, the  
delivery occurs via a circular strip around the cell (Fig. 7b),  
revealing the fact that the permeabilization is no longer  
limited to the cell poles due to the cell rotation.  
Furthermore, when the device with a spiral narrow section 
(shown in Fig. 2d) is used, the generated secondary Dean 
flow gives rise to combined vortex motion and rotation  
that render the entire cell surface permeabilized and  
delivered with DNA (Fig. 7c), with the same electric  
parameters used as in the device with the straight  
narrow section. Figure 7d,e shows the transfection  
efficiency and cell viability when the devices in Figure 2c,d 
are used under the same operational parameters (Q  =  150 µl min − 1, V  =  207–363 V and these conditions generate T2 of 5 ms 
and E2 of 400–700 V cm
 − 1). The data indicate that the device with a spiral narrow section yields much higher transfection 
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Figure 6 | Flow-through electroporation for large-volume cell transfection. 
(a–d) The typical phase-contrast image (a), fluorescent image (b) and 
results (c,d) of CHO-K1 cell transfection by pEGFP-C1 plasmids following our 
protocol. The data shown in a–c are obtained using the device in Figure 2a.  
The data in d are obtained using the device in Figure 2b. Cell images are 
taken at 48 h post-electroporation. The transfection efficiency and cell 
viability vary with the total duration in the narrow sections (T2) under the 
identical field intensity (E2  =  800 V cm
 − 1). All data points are generated by 
triplicate experiments. Modified from ref. 35 with permission from Elsevier.
Figure 7 | Comparison of plasmid DNA  
delivery into CHO-K1 cells in the devices  
with a straight narrow section and a spiral  
one of the same dimensions. (See designs shown 
in Fig. 2c,d). (a–c) Epifluorescence images (i)  
and 3D reconstruction images generated 
by confocal fluorescence imaging (ii) of 
CHO-K1 cells delivered with YOYO-1–labeled 
pEGFP-C1 plasmids. The images in (ii) focus 
on representative individual cells from the 
cell populations shown in (i). (a–c) Cells are 
processed in the device (a) with a straight  
narrow section (E2  =  900 V cm
 − 1; T2  =  0.5 ms); 
(b) with a straight narrow section (E2  =  700 V 
cm − 1; T2  =  5 ms); and  (c) with a spiral narrow  
section (E2  =  700 V cm
 − 1; T2  =  5 ms). The images 
are taken immediately after electroporation  
(see procedure detailed in Box 1). (d,e) The 
results on CHO-K1 cell transfection by pEGFP-C1 
plasmid. The transfection efficiency (d) and  
cell viability (e) vary with E2 under the fixed  
flow rate Q of 150 µl min − 1 and T2 of 5 ms. 
All data points are generated by triplicate 
experiments, and two-tailed Student’s t test is applied to evaluate the data. (*) indicates significant difference at P  <  0.05 and (**) indicates significant 
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